FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3860711000001109: Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25685901000001118 Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38295701000001110 Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Ltd) 25 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Is a Neomycin 0.25% / Gramicidin 0.025% ointment 25 gram true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Is pack of Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) false Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has active ingredient Neomycin sulfate false Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has active ingredient Gramicidin false Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has AMP Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Neomycin true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has specific active ingredient Gramicidin true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram Has basis of strength substance Neomycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start